FOXW Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (27 saus. 2023 @ 22:06):

Stats
Dzisiejszy wolumen	730.00
Średni wolumen	5 741.00
Kapitalizacja rynkowa	0.00
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0480 (0.47%)

Insider Trading

Date	Person	Action	Amount	type
2021-01-19	Foxwayne Enterprises Acquisition Sponsor Llc	Buy	100 000	Class B common stock, par value $0.0001 per share

INSIDER POWER
0.00
Last 0 transactions
Buy: 0 \| Sell: 0

Wolumen Korelacja

Długi: -0.14 (neutral)

Krótki: -0.63 (weak negative)

Signal:(48.923) Neutral

FoxWayne Enterprises Korelacja

10 Najbardziej pozytywne korelacje
GETVV	0.845

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

FoxWayne Enterprises Korelacja - Waluta/Towar

0.42
( neutral )

0.53
( weak )

0.00
( neutral )

0.38
( neutral )

-0.79
( moderate negative )

-0.26
( neutral )

FoxWayne Enterprises Finanse

Annual	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.145

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.145

FY	2020
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.00100

Financial Reports:

No articles found.

FoxWayne Enterprises

FoxWayne Enterprises Acquisition Corp. does not have significant business. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire a business in the biotechnology and/or telemedicine sector of the healthcare industry in North America. The company was incorporated in 2020 and is based in New York, New York.